Induction of Translational Readthrough on Protein Tyrosine Phosphatases Targeted by Premature Termination Codon Mutations in Human Disease.
Laforin
Nonsense mutation
PTEN
Premature termination codon
Protein translation
Translational readthrough
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
26
12
2023
pubmed:
26
12
2023
entrez:
26
12
2023
Statut:
ppublish
Résumé
Nonsense mutations generating premature termination codons (PTCs) in various genes are frequently associated with somatic cancer and hereditary human diseases since PTCs commonly generate truncated proteins with defective or altered function. Induced translational readthrough during protein biosynthesis facilitates the incorporation of an amino acid at the position of a PTC, allowing the synthesis of a complete protein. This may evade the pathological effect of the PTC mutation and provide new therapeutic opportunities. Several protein tyrosine phosphatases (PTPs) genes are targeted by PTC in human disease, the tumor suppressor PTEN being the more prominent paradigm. Here, using PTEN and laforin as examples, two PTPs from the dual-specificity phosphatase subfamily, we describe methodologies to analyze in silico the distribution and frequency of pathogenic PTC in PTP genes. We also summarize laboratory protocols and technical notes to study the induced translational readthrough reconstitution of the synthesis of PTP targeted by PTC in association with disease in cellular models.
Identifiants
pubmed: 38147205
doi: 10.1007/978-1-0716-3569-8_1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-19Informations de copyright
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Gold B (2017) Somatic mutations in cancer: stochastic versus predictable. Mutat Res Genet Toxicol Environ Mutagen 814:37–46. https://doi.org/10.1016/j.mrgentox.2016.12.006
doi: 10.1016/j.mrgentox.2016.12.006
pubmed: 28137366
Mort M, Ivanov D, Cooper DN, Chuzhanova NA (2008) A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat 29(8):1037–1047. https://doi.org/10.1002/humu.20763
doi: 10.1002/humu.20763
pubmed: 18454449
Zhang L, Shay JW (2017) Multiple roles of APC and its therapeutic implications in colorectal cancer. J Natl Cancer Inst 109(8). https://doi.org/10.1093/jnci/djw332
Aartsma-Rus A, Ginjaar IB, Bushby K (2016) The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 53(3):145–151. https://doi.org/10.1136/jmedgenet-2015-103387
doi: 10.1136/jmedgenet-2015-103387
pubmed: 26754139
Hug N, Longman D, Caceres JF (2016) Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res 44(4):1483–1495. https://doi.org/10.1093/nar/gkw010
doi: 10.1093/nar/gkw010
pubmed: 26773057
pmcid: 4770240
Nesta AV, Tafur D, Beck CR (2021) Hotspots of human mutation. Trends Genet: TIG 37(8):717–729. https://doi.org/10.1016/j.tig.2020.10.003
doi: 10.1016/j.tig.2020.10.003
pubmed: 33199048
Zhang M, Yang D, Gold B (2021) Origins of nonsense mutations in human tumor suppressor genes. Mutat Res 823:111761. https://doi.org/10.1016/j.mrfmmm.2021.111761
doi: 10.1016/j.mrfmmm.2021.111761
pubmed: 34461460
Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2015) Translational readthrough potential of natural termination codons in eucaryotes--the impact of RNA sequence. RNA Biol 12(9):950–958. https://doi.org/10.1080/15476286.2015.1068497
doi: 10.1080/15476286.2015.1068497
pubmed: 26176195
pmcid: 4615788
Keeling KM, Xue X, Gunn G, Bedwell DM (2014) Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet 15:371–394. https://doi.org/10.1146/annurev-genom-091212-153527
doi: 10.1146/annurev-genom-091212-153527
pubmed: 24773318
pmcid: 5304456
Morais P, Adachi H, Yu YT (2020) Suppression of nonsense mutations by new emerging technologies. Int J Mol Sci 21(12). https://doi.org/10.3390/ijms21124394
Nagel-Wolfrum K, Moller F, Penner I, Baasov T, Wolfrum U (2016) Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs). BioDrugs 30(2):49–74. https://doi.org/10.1007/s40259-016-0157-6
doi: 10.1007/s40259-016-0157-6
pubmed: 26886021
Palma M, Lejeune F (2021) Deciphering the molecular mechanism of stop codon readthrough. Biol Rev Camb Philos Soc 96(1):310–329. https://doi.org/10.1111/brv.12657
doi: 10.1111/brv.12657
pubmed: 33089614
Dabrowski M, Bukowy-Bieryllo Z, Jackson CL, Zietkiewicz E (2021) Properties of non-aminoglycoside compounds used to stimulate translational readthrough of PTC mutations in primary ciliary dyskinesia. Int J Mol Sci 22(9). https://doi.org/10.3390/ijms22094923
Roy B, Friesen WJ, Tomizawa Y, Leszyk JD, Zhuo J, Johnson B, Dakka J, Trotta CR, Xue X, Mutyam V, Keeling KM, Mobley JA, Rowe SM, Bedwell DM, Welch EM, Jacobson A (2016) Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proc Natl Acad Sci U S A 113(44):12508–12513. https://doi.org/10.1073/pnas.1605336113
doi: 10.1073/pnas.1605336113
pubmed: 27702906
pmcid: 5098639
Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2018) Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. Mol Med 24(1):25. https://doi.org/10.1186/s10020-018-0024-7
doi: 10.1186/s10020-018-0024-7
pubmed: 30134808
pmcid: 6016875
Luna S, Torices L, Mingo J, Amo L, Rodriguez-Escudero I, Ruiz-Ibarlucea P, Erramuzpe A, Cortes JM, Tejada MI, Molina M, Nunes-Xavier CE, Lopez JI, Cid VJ, Pulido R (2021) A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons. Hum Mutat 42(5):551–566. https://doi.org/10.1002/humu.24186
doi: 10.1002/humu.24186
pubmed: 33600059
Bordeira-Carrico R, Pego AP, Santos M, Oliveira C (2012) Cancer syndromes and therapy by stop-codon readthrough. Trends Mol Med 18(11):667–678. https://doi.org/10.1016/j.molmed.2012.09.004
doi: 10.1016/j.molmed.2012.09.004
pubmed: 23044248
Martins-Dias P, Romao L (2021) Nonsense suppression therapies in human genetic diseases. Cell Mol Life Sci 78(10):4677–4701. https://doi.org/10.1007/s00018-021-03809-7
doi: 10.1007/s00018-021-03809-7
pubmed: 33751142
Hendriks WJ, Elson A, Harroch S, Pulido R, Stoker A, den Hertog J (2013) Protein tyrosine phosphatases in health and disease. FEBS J 280(2):708–730. https://doi.org/10.1111/febs.12000
doi: 10.1111/febs.12000
pubmed: 22938156
Hendriks WJ, Pulido R (2013) Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities. Biochim Biophys Acta 1832(10):1673–1696. https://doi.org/10.1016/j.bbadis.2013.05.022
doi: 10.1016/j.bbadis.2013.05.022
pubmed: 23707412
Pulido R, Stoker AW, Hendriks WJ (2013) PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease. Hum Mol Genet 22(R1):R66–R76. https://doi.org/10.1093/hmg/ddt347
doi: 10.1093/hmg/ddt347
pubmed: 23900072
Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA (2018) Lafora disease - from pathogenesis to treatment strategies. Nat Rev Neurol 14(10):606–617. https://doi.org/10.1038/s41582-018-0057-0
doi: 10.1038/s41582-018-0057-0
pubmed: 30143794
pmcid: 6317072
Pulido R (2015) PTEN: a yin-yang master regulator protein in health and disease. Methods 77–78:3–10. https://doi.org/10.1016/j.ymeth.2015.02.009
doi: 10.1016/j.ymeth.2015.02.009
pubmed: 25843297
Auld DS, Inglese J (2004) Interferences with luciferase reporter enzymes. In: Markossian S, Grossman A, Brimacombe K et al (eds) Assay guidance manual, Bethesda
Misawa K, Kikuno RF (2009) Evaluation of the effect of CpG hypermutability on human codon substitution. Gene 431(1–2):18–22. https://doi.org/10.1016/j.gene.2008.11.006
doi: 10.1016/j.gene.2008.11.006
pubmed: 19059467
Fryxell KJ, Moon WJ (2005) CpG mutation rates in the human genome are highly dependent on local GC content. Mol Biol Evol 22(3):650–658. https://doi.org/10.1093/molbev/msi043
doi: 10.1093/molbev/msi043
pubmed: 15537806
Zhao Z, Jiang C (2007) Methylation-dependent transition rates are dependent on local sequence lengths and genomic regions. Mol Biol Evol 24(1):23–25. https://doi.org/10.1093/molbev/msl156
doi: 10.1093/molbev/msl156
pubmed: 17056644
Cohen S, Kramarski L, Levi S, Deshe N, Ben David O, Arbely E (2019) Nonsense mutation-dependent reinitiation of translation in mammalian cells. Nucleic Acids Res 47(12):6330–6338. https://doi.org/10.1093/nar/gkz319
doi: 10.1093/nar/gkz319
pubmed: 31045216
pmcid: 6614817
Torices L, de Las Heras J, Arango-Lasprilla JC, Cortes JM, Nunes-Xavier CE, Pulido R (2021) MMADHC premature termination codons in the pathogenesis of cobalamin D disorder: potential of translational readthrough reconstitution. Mol Genet Metab Rep 26:100710. https://doi.org/10.1016/j.ymgmr.2021.100710
doi: 10.1016/j.ymgmr.2021.100710
pubmed: 33552904
pmcid: 7847965
Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN (2017) The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136(6):665–677. https://doi.org/10.1007/s00439-017-1779-6
doi: 10.1007/s00439-017-1779-6
pubmed: 28349240
pmcid: 5429360
Landrum MJ, Kattman BL (2018) ClinVar at five years: delivering on the promise. Hum Mutat 39(11):1623–1630. https://doi.org/10.1002/humu.23641
doi: 10.1002/humu.23641
pubmed: 30311387
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H, Sondka Z, Thompson S, De T, Campbell PJ (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45(D1):D777–D783. https://doi.org/10.1093/nar/gkw1121
doi: 10.1093/nar/gkw1121
pubmed: 27899578
Mingo J, Erramuzpe A, Luna S, Aurtenetxe O, Amo L, Diez I, Schepens JT, Hendriks WJ, Cortes JM, Pulido R (2016) One-tube-only standardized site-directed mutagenesis: an alternative approach to generate amino acid substitution collections. PLoS One 11(8):e0160972. https://doi.org/10.1371/journal.pone.0160972
doi: 10.1371/journal.pone.0160972
pubmed: 27548698
pmcid: 4993582
Ausubel FM (2002) Short protocols in molecular biology: a compendium of methods from current protocols in molecular biology, 5th edn. Wiley, New York
Alonso A, Pulido R (2016) The extended human PTPome: a growing tyrosine phosphatase family. FEBS J 283(8):1404–1429. https://doi.org/10.1111/febs.13600
doi: 10.1111/febs.13600
pubmed: 26573778
Gentry MS, Roma-Mateo C, Sanz P (2013) Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. FEBS J 280(2):525–537. https://doi.org/10.1111/j.1742-4658.2012.08549.x
doi: 10.1111/j.1742-4658.2012.08549.x
pubmed: 22364389
Torres J, Navarro S, Rogla I, Ripoll F, Lluch A, Garcia-Conde J, Llombart-Bosch A, Cervera J, Pulido R (2001) Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues. Eur J Cancer 37(1):114–121
doi: 10.1016/S0959-8049(00)00366-X
pubmed: 11165138
Luna S, Mingo J, Aurtenetxe O, Blanco L, Amo L, Schepens J, Hendriks WJ, Pulido R (2016) Tailor-made protein tyrosine phosphatases: in vitro site-directed mutagenesis of PTEN and PTPRZ-B. Methods Mol Biol 1447:79–93. https://doi.org/10.1007/978-1-4939-3746-2_5
doi: 10.1007/978-1-4939-3746-2_5
pubmed: 27514801
Mingo J, Luna S, Gaafar A, Nunes-Xavier CE, Torices L, Mosteiro L, Ruiz R, Guerra I, Llarena R, Angulo JC, Lopez JI, Pulido R (2019) Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. NPJ Precis Oncol 3:11. https://doi.org/10.1038/s41698-019-0083-4
doi: 10.1038/s41698-019-0083-4
pubmed: 30993208
pmcid: 6465295
Moreno D, Towler MC, Hardie DG, Knecht E, Sanz P (2010) The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits. Mol Biol Cell 21(15):2578–2588. https://doi.org/10.1091/mbc.e10-03-0227
doi: 10.1091/mbc.e10-03-0227
pubmed: 20534808
pmcid: 2912345